Transcription Locations: What Actually Happens and Where
Transcription is the process where a segment of DNA is copied into RNA by the enzyme RNA polymerase. It happens in different places depending on what kind of cell you're talking about, and this distinction matters a lot if you're studying for exams or working in a lab. The short answer is that in eukaryotic cells, transcription takes place in the nucleus, while in prokaryotic cells, it occurs in the cytoplasm since they lack a membrane-bound nucleus altogether. Let me walk through how this actually works in practice, because the textbook explanation leaves out some of the messier details you run into when you're dealing with real cells. In eukaryotic cells, the DNA is packed away inside the nuclear envelope. RNA polymerase can't just access it from anywhere in the cell. So transcription happens inside the nucleus, where the chromatin is unpacked and the polymerase binds to promoter regions to begin synthesizing an RNA strand complementary to the DNA template. After the RNA is made, it still has to exit the nucleus through nuclear pores before ribosomes in the cytoplasm can translate it into protein. This spatial separation of transcription and translation is one of the fundamental differences between eukaryotes and prokaryotes.
In prokaryotes like bacteria, there's no nucleus. The DNA floats in the cytoplasm as a nucleoid region, and RNA polymerase accesses it directly there. Transcription and translation can happen simultaneously — ribosomes can start translating an mRNA molecule even before transcription of that same molecule is finished. This coupling doesn't exist in eukaryotes because of the nuclear envelope barrier. There are also specialized cases worth noting. Mitochondria and chloroplasts have their own DNA and their own transcription machinery. Transcription inside these organelles takes place within the organelle itself, not in the nucleus. The RNA polymerase used here is actually encoded by the organelle's genome and resembles bacterial RNA polymerase more than the eukaryotic nuclear version. This is one of the pieces of evidence supporting the endosymbiotic theory. I ran into a practical problem with this a few years ago while setting up an in vitro transcription assay. We were trying to isolate nuclear RNA from cultured mammalian cells and keep it separate from mitochondrial RNA for a quantitative PCR experiment. The standard nuclei isolation protocol using detergent lysis and centrifugation worked most of the time, but we kept seeing mitochondrial rRNA contaminants in our nuclear prep. The fix was switching to a sucrose gradient purification step instead of simple centrifugation, which separated the nuclei from the free mitochondria much more cleanly. Without that extra step, our data was garbage because the contamination skewed the expression ratios.
One thing beginners consistently miss is the assumption that transcription only produces mRNA. That's not true. RNA polymerase transcribes all types of RNA — messenger RNA, transfer RNA, ribosomal RNA, and various non-coding RNAs like microRNAs and long non-coding RNAs. Each type is made by slightly different polymerases or different promoter architectures. In eukaryotes, RNA polymerase II handles mRNA and most snRNAs, RNA polymerase I handles ribosomal RNA genes, and RNA polymerase III handles tRNAs and 5S rRNA. If you're designing an experiment that targets one type, you need to make sure your primers or probes won't cross-react with transcripts made by the other polymerases. Another counter-intuitive point is that transcription doesn't always produce a continuous RNA molecule. Eukaryotic genes contain introns — non-coding sequences that get transcribed into the initial RNA transcript but then removed by splicing before the mature RNA exits the nucleus. The transcription machinery doesn't skip the introns during synthesis; it transcribes everything and then the spliceosome goes back and edits the transcript. This means the primary transcript, called pre-mRNA, is actually longer than the final functional RNA. Some genes have so many introns that the pre-mRNA can be two or three times the length of the mature mRNA. The process also has bottlenecks. Promoter clearance is one of them. RNA polymerase binds to the promoter, starts synthesizing a short RNA strand, and then often pauses or backtracks before committing to full-length elongation. This is called promoter-proximal pausing and it's a regulated checkpoint, especially in metazoan cells. Factors like P-TEFb need to phosphorylate the polymerase to release it from the pause. If that step fails, transcription stalls and the gene stays silent regardless of how much activator protein is bound to the enhancer. This is one reason why simply adding more transcription factor to a system doesn't always increase output proportionally.
Get the Full Details
There are scenarios where the standard model breaks down entirely. Some viruses, like influenza, carry their own RNA-dependent RNA polymerase and replicate their genomes in the nucleus despite being RNA viruses. Retrotransposons and retroviruses reverse-transcribe RNA into DNA and integrate it into the host genome, which means the transcription of their new DNA copies happens in the nucleus but the original template was RNA. And in some pathological conditions, like certain neurodegenerative diseases, RNA can accumulate in the cytoplasm in aggregates that interfere with normal transcriptional and translational machinery. These are edge cases but they matter if you're working beyond textbook biology. If you're studying this for a course, focus on the nucleus versus cytoplasm distinction and understand why it exists. If you're working in a lab, pay attention to which RNA polymerase your gene of interest uses and make sure your isolation and detection methods account for the processing steps that happen after transcription. The biology is straightforward until you try to measure it precisely.
